Rezolute ( (RZLT) ) has issued an announcement.
Rezolute, Inc. announced the election of Erik Harris to its Board of Directors, effective March 25, 2025. Mr. Harris, deemed independent by Nasdaq standards, brings extensive experience from his roles at Ultragenyx Pharmaceutical Inc. and other life science companies. His appointment is expected to enhance Rezolute’s strategic direction, leveraging his commercial and management expertise. Mr. Harris will receive standard board compensation, including stock options, and his role is anticipated to strengthen the company’s industry positioning.
More about Rezolute
YTD Price Performance: -43.30%
Average Trading Volume: 546,610
Technical Sentiment Signal: Strong Buy
Current Market Cap: $176.8M
Learn more about RZLT stock on TipRanks’ Stock Analysis page.